Salem News: “AKS-452: The newest vaccine; COVID-19 shot developed by Beverly company reaches trial stage”
Hopkinton Indepedent on Twitter: “Good morning Hopkinton, here is your daily update. Read about the important role LakePharma may play in the fight against COVID-19 and see which popular town eatery is closing for the winter. Also, see the sign of peace from a Hayden Rowe family and donβt miss tonightβs Open Space Preservation Commission meeting”
Eagle-Tribune: “COVID-19 vaccine developed by Beverly company reaches trial stage”
Dell’s Blog Campaign Clicks In
Drug Discovery & Development on Twitter: “An inexpensive investigational #Vaccine is stable for weeks at room temperature & can potentially be used for both prime & boost #Vaccination. Developer Akston #Biosciences, has hooked up with @LakePharma to #Manufacture it https://drugdiscoverytrends.com/akston-biosciences-and-lakepharma-team-up-on-second-generation-covid-19-vaccine/β¦ #ClinicalTrials @researchumcg”
PitchBook: “Eurazeo to sell pharma company Seqens”
CommPro.Biz: “9 Media Trends for 2022: Supply Chain, Healthcare, Infrastructure, HR, the Future of Money, and Cybersecurity Will Dominate the Media Landscape”
Grant Welker on Twitter: “The biotech firm LakePharma has signed a partnership agreement with a North Shore therapeutics company to jointly develop a potential COVID-19 vaccine at its Hopkinton facility”
M2 Pharma: “Akston Biosciences collaborates with LakePharma to develop commercial quantities of Akston’s COVID-19 vaccine candidate”
Digital Engineering247: “The Coming of Age of AI and Machine Learning in Design: Simulation and manufacturing can benefit from AI, but adoption hurdles still exist”
CommPro.Biz: “7 Media Trends for 2021 include Supply Chains, Healthcare, Telepresence and Customer Experiences”
Community Advocate: “Westborough nurse honored by Boston Globe”